NeurAxis (NRXS) Competitors

Spectral AI (NASDAQ:MDAI) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Which has better earnings and valuation, MDAI or NRXS?

NeurAxis has lower revenue, but higher earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$29.58M	2.32	-$15.31M	-$0.54	-5.01
NeurAxis	$2.93M	6.29	-$14.63M	-$1.19	-2.15

Is MDAI or NRXS more profitable?

Spectral AI has a net margin of -30.75% compared to NeurAxis' net margin of -492.76%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-30.75%	N/A	-11.37%
NeurAxis	-492.76%	N/A	-641.25%

Which has more volatility and risk, MDAI or NRXS?

Spectral AI has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.09, suggesting that its share price is 209% more volatile than the S&P 500.

Does the media refer more to MDAI or NRXS?

In the previous week, Spectral AI had 1 more articles in the media than NeurAxis. MarketBeat recorded 5 mentions for Spectral AI and 4 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.67 beat Spectral AI's score of 0.53 indicating that NeurAxis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeurAxis	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer MDAI or NRXS?

Spectral AI currently has a consensus target price of $4.75, suggesting a potential upside of 75.60%. NeurAxis has a consensus target price of $7.00, suggesting a potential upside of 173.44%. Given NeurAxis' higher probable upside, analysts clearly believe NeurAxis is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders have more ownership in MDAI or NRXS?

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 30.7% of Spectral AI shares are owned by insiders. Comparatively, 26.4% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Spectral AI beats NeurAxis on 10 of the 16 factors compared between the two stocks.